Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients.
Koh
Kwang Kon
KK
Department of Cardiology, Gachon University, Gil Medical Center, Incheon, Korea. Electronic address: kwangk@gilhospital.com.
Quon
Michael J
MJ
Diabetes Unit, National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethesda, Maryland.
Han
Seung Hwan
SH
Department of Cardiology, Gachon University, Gil Medical Center, Incheon, Korea.
Lee
Yonghee
Y
Department of Statistics, University of Seoul, Seoul, Korea.
Kim
Soo Jin
SJ
Department of Cardiology, Gachon University, Gil Medical Center, Incheon, Korea.
Shin
Eak Kyun
EK
Department of Cardiology, Gachon University, Gil Medical Center, Incheon, Korea.
D000328:Adult; D000368:Aged; D000069059:Atorvastatin; D001786:Blood Glucose / Q000187:drug effects*; D004311:Double-Blind Method; D005260:Female; D006538:Heptanoic Acids / Q000494:pharmacology*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D006937:Hypercholesterolemia / Q000188:drug therapy*; D007328:Insulin / Q000097:blood*; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D011758:Pyrroles / Q000494:pharmacology*; D016896:Treatment Outcome
D001786:Blood Glucose; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007328:Insulin; D011758:Pyrroles; D000069059:Atorvastatin